drugset / Trial / NCT07566390

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

NCT07566390 ↗

Phase 1 Recruiting 48 enrolled Novo Nordisk A/S
RandomizedSequentialDouble-blindTreatment

Summary

The purpose of this clinical study is to find out if NNC0113-5840 is safe for treating people with excess body weight. There are 2 study treatments in this study, participants will get either NNC0113-5840 (the product being tested) or Placebo (treatment that has no active medicine in it), Which treatment participants get is decided by chance.

Timeline

Start
2026-05-01
Primary completion
2026-11-26
Completion
2026-11-26

Drugs

EvaluationDrugModalityDoseRoute
Subject NNC0113-5840 Unknown — Subcutaneous

Indications